Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Amadix logo — Early cancer detection in blood

Amadix

Early cancer detection in blood

Founded 2010 Spain Spain 43 employees Grant Total: $4.55M Biopharma, Biotechnology +3

General Information

Company Name Amadix
Founded Year 2010
Location Spain Spain +1
Founders / Decision Makers
Team member
Employees 43
Industries Biopharma, Biotechnology, Health Care +2
Funding Stage Grant
Social

Get notified when Amadix moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Amadix

Amadix is a leading molecular diagnostics company based in Spain, founded in 2010. The company's slogan "Early cancer detection in blood" aligns with their mission of extending people's lives by developing disruptive technologies for early cancer detection in blood. Amadix focuses on liquid biopsy and is dedicated to developing innovative diagnostic tests for detecting tumors years in advance, before symptoms appear. The company recently received a €2.50M grant investment on 06 October 2021 from The European Innovation Council. With its significant focus on the biopharma, biotechnology, health care, and pharmaceutical industries, Amadix is well-positioned to make a meaningful impact in the field of cancer diagnostics.

Taxonomy: Molecular Diagnostics, Liquid Biopsy, Cancer Detection, Innovative Diagnostic Tests, Early Detection, Disruptive Technologies, Tumor Detection, Medical Technology

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant •••••• 1
Investor
06 Oct 2021
Non Equity Assistance •••••• 1
Investor
16 Nov 2018
Grant •••••• 1 •••• •••• 01 Jul 2017
Venture Round •••••• 3
Investor Investor
•••• •••• 		10 Feb 2013

Latest News

View All
EIC Scaling Club'a katılan 72 teknoloji şirketi — Webrazzi
EIC Scaling Club'a katılan 72 teknoloji şirketi
Webrazzi Oct 21, 2024

Amadix Alternatives & Competitors

Amadix vs
Traceguard Technologies
Traceguard Technologies

Advancing security with innovative solutions for detecting explosives, narcotics, and hazardous mate...

Information Technology
Amadix vs
Triton Tech
Triton Tech Turkey

Develops instruments for identifying pollutants in water.

Climate Tech, ESG
Amadix vs
Bialanx, Inc.
Bialanx, Inc.

Developing innovative bioelectronic detection platforms for real-time, label-free biochemical applic...

Grant
2-10 employees
Biotechnology, Semiconductor
Compare Amadix vs Bialanx, Inc.
Also compare with: Amadix vs Cranebio Co.,Ltd Cranebio Co.,Ltd Amadix vs AeenaDx AeenaDx

FAQ About Amadix

Early cancer detection in blood
Amadix was founded in 2010.
Amadix is headquartered in Spain.
Amadix operates in the following industries: Biopharma, Biotechnology, Health Care, Life Sciences, Pharmaceutical.
Amadix has approximately 43 employees.
Amadix has completed 4 funding rounds, raising a total of $4.55M. The latest funding stage is Grant.
Top alternatives and competitors to Amadix include Traceguard Technologies, Triton Tech, Bialanx, Inc., Cranebio Co.,Ltd, AeenaDx. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Amadix and Traceguard Technologies are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Amadix and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy